SAN FRANCISCO, Aug. 21, 2001 (PRIMEZONE) -- Please disregard the previous release relating to Pharmacopeia Incorporated's Special Announcement (Nasdaq:PCOP) on Wednesday, August 22, 2001 at 8:30 AM Eastern Time. The company has not announced any such announcement and all information contained in the previous press release should be disregarded.
About Pharmacopeia
Pharmacopeia (www.pharmacopeia.com) is a leader in enabling science and technology that accelerates and improves the drug discovery and chemical development processes. Pharmacopeia's software subsidiary, Accelrys, develops and commercializes molecular modeling and simulation software for the life sciences and materials research, cheminformatics and decision support systems, and bioinformatics tools including gene sequence analysis. The business also provides consulting services to its customers in drug discovery and chemical development. Pharmacopeia's Drug Discovery segment integrates proprietary small molecule combinatorial and medicinal chemistry, high-throughput screening, in-vitro pharmacology, computational methods and informatics to discover and optimize lead compounds. Pharmacopeia employs approximately 750 people, generated 2000 revenues of approximately $119 million, and is headquartered in Princeton, NJ.
About StreetFusion
StreetFusion, the global financial events network, links approximately 6,200 public companies, thousands of leading buyside and sellside firms, and millions of individual investors. The company hosts the most comprehensive and accurate collection of financial event webcasts and event logistics available anywhere. StreetFusion has simplified and streamlined financial communications, enabling the secure distribution of time sensitive and critical investment information. Online event planning, event publishing, and event webcasting ensure targeted distribution with pinpoint accuracy. For information on StreetFusion's services, visit www.streetfusion.com or call toll-free (877) 343-0020 or (415) 343-3000.